Dimensional Fund Advisors
ANRO icon

Dimensional Fund Advisors’s Alto Neuroscience ANRO Stock Holding History

Dimensional Fund Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
42,561
+3,237
+8% +$74.8K ﹤0.01% 2846
2026
Q1 		$884K Buy
39,324
+8,148
+26% +$151K ﹤0.01% 2862
2025
Q4 		$555K Buy
+31,176
New +$393K ﹤0.01% 2958

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Dimensional Fund Advisors's ANRO Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Alto Neuroscience (ANRO) stake by 8.2% in Q2 2026, buying an estimated $74.8K and bringing the position to 42,561 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Dimensional Fund Advisors first reported a position in ANRO in Q4 2025 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Dimensional Fund Advisors held 42,561 shares of Alto Neuroscience worth $1.12M as of Q2 2026.
  • Dimensional Fund Advisors bought 3,237 Alto Neuroscience shares in Q2 2026, an estimated $74.8K.
  • Alto Neuroscience made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2846 holding.
  • Dimensional Fund Advisors first reported a position in Alto Neuroscience in Q4 2025 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.